Cargando…
Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810262/ https://www.ncbi.nlm.nih.gov/pubmed/33463051 http://dx.doi.org/10.1002/ctm2.275 |
_version_ | 1783637279144673280 |
---|---|
author | Rey, Esther Ampuero, Javier Molina‐Jiménez, Francisca Marañón, Patricia García‐García, Yaiza Múñoz‐Hernández, Rocío Romero‐Gómez, Manuel García‐Monzón, Carmelo Majano, Pedro González‐Rodríguez, Águeda |
author_facet | Rey, Esther Ampuero, Javier Molina‐Jiménez, Francisca Marañón, Patricia García‐García, Yaiza Múñoz‐Hernández, Rocío Romero‐Gómez, Manuel García‐Monzón, Carmelo Majano, Pedro González‐Rodríguez, Águeda |
author_sort | Rey, Esther |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7810262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78102622021-01-22 Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation Rey, Esther Ampuero, Javier Molina‐Jiménez, Francisca Marañón, Patricia García‐García, Yaiza Múñoz‐Hernández, Rocío Romero‐Gómez, Manuel García‐Monzón, Carmelo Majano, Pedro González‐Rodríguez, Águeda Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-01-15 /pmc/articles/PMC7810262/ /pubmed/33463051 http://dx.doi.org/10.1002/ctm2.275 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to Editor Rey, Esther Ampuero, Javier Molina‐Jiménez, Francisca Marañón, Patricia García‐García, Yaiza Múñoz‐Hernández, Rocío Romero‐Gómez, Manuel García‐Monzón, Carmelo Majano, Pedro González‐Rodríguez, Águeda Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation |
title | Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation |
title_full | Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation |
title_fullStr | Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation |
title_full_unstemmed | Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation |
title_short | Sofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation |
title_sort | sofosbuvir improves hcv‐induced insulin resistance by blocking irs1 degradation |
topic | Letter to Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810262/ https://www.ncbi.nlm.nih.gov/pubmed/33463051 http://dx.doi.org/10.1002/ctm2.275 |
work_keys_str_mv | AT reyesther sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT ampuerojavier sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT molinajimenezfrancisca sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT maranonpatricia sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT garciagarciayaiza sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT munozhernandezrocio sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT romerogomezmanuel sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT garciamonzoncarmelo sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT majanopedro sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation AT gonzalezrodriguezagueda sofosbuvirimproveshcvinducedinsulinresistancebyblockingirs1degradation |